Characteristics and outcomes of cubital tunnel decompression in diabetic patients receiving glucagon-like peptide-1 receptor agonists
Background: Cubital tunnel release (CuTR) relieves ulnar nerve compression; however, about 35% of patients who undergo this procedure develop persistent neuropathy and about 7% require revision. Type 2 diabetes mellitus (T2DM) worsens ulnar neuropathy, whereas glucagon-like peptide-1 receptor agonis...
Saved in:
| Published in: | Clinics in shoulder and elbow pp. 403 - 410 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
대한견주관절학회
01.12.2025
|
| Subjects: | |
| ISSN: | 2383-8337, 2288-8721 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background: Cubital tunnel release (CuTR) relieves ulnar nerve compression; however, about 35% of patients who undergo this procedure develop persistent neuropathy and about 7% require revision. Type 2 diabetes mellitus (T2DM) worsens ulnar neuropathy, whereas glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be neuroprotective. We compared short- (90-day) and mid-term (2-year) CuTR outcomes in diabetic patients who did or did not receive perioperative GLP-1 RA treatment.Methods: TriNetX identified adults (≥18 years) with T2DM who underwent primary CuTR during the period 2015–2023, and who underwent at least 2 years of follow-up. The experimental cohort had received an active GLP-1 RA prescription at surgery, while the controls had not. Exclusion criteria were T1DM, pancreatitis, multiple endocrine neoplasia 2, systemic steroids, end-stage renal disease, or prior major CuTR. Propensity-score matching (1:1) balanced demographics, body mass index, glycated hemoglobin (HbA1c), creatinine, and comorbidities. Outcomes were captured using International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) and Current Procedural Terminology (CPT) codes.Results: After matching, 1,766 pairs of patients (mean age, 58 years; 46% female) were analyzed. At 90 days, fewer GLP-1 RA users had emergency-department visits than non-users (8.9% vs. 10.7%, P=0.048). Despite higher HbA1c at each timepoint, GLP-1 RA users showed a larger decline. At 2 years, GLP-1 RA exposure was associated with fewer reoperations (5.2% vs. 6.9%, P=0.028), less frequent neuropathy (23.4% vs. 30.4%, P<0.001), and fewer inpatient admissions (14.6% vs. 17.2%, P=0.030). Major medical complications did not differ in occurrence between the groups.Conclusions: Perioperative GLP-1 RA therapy in diabetic patients undergoing CuTR correlated with fewer 90-day emergency visits and lower 2-year risks of revisional surgery and ICD-coded ulnar neuropathy (all-cause, non-adjudicated).. These findings support a potential protective role of GLP-1 RAs in this surgical population. Evidence: III. KCI Citation Count: 0 |
|---|---|
| AbstractList | Background: Cubital tunnel release (CuTR) relieves ulnar nerve compression; however, about 35% of patients who undergo this procedure develop persistent neuropathy and about 7% require revision. Type 2 diabetes mellitus (T2DM) worsens ulnar neuropathy, whereas glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be neuroprotective. We compared short- (90-day) and mid-term (2-year) CuTR outcomes in diabetic patients who did or did not receive perioperative GLP-1 RA treatment.Methods: TriNetX identified adults (≥18 years) with T2DM who underwent primary CuTR during the period 2015–2023, and who underwent at least 2 years of follow-up. The experimental cohort had received an active GLP-1 RA prescription at surgery, while the controls had not. Exclusion criteria were T1DM, pancreatitis, multiple endocrine neoplasia 2, systemic steroids, end-stage renal disease, or prior major CuTR. Propensity-score matching (1:1) balanced demographics, body mass index, glycated hemoglobin (HbA1c), creatinine, and comorbidities. Outcomes were captured using International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) and Current Procedural Terminology (CPT) codes.Results: After matching, 1,766 pairs of patients (mean age, 58 years; 46% female) were analyzed. At 90 days, fewer GLP-1 RA users had emergency-department visits than non-users (8.9% vs. 10.7%, P=0.048). Despite higher HbA1c at each timepoint, GLP-1 RA users showed a larger decline. At 2 years, GLP-1 RA exposure was associated with fewer reoperations (5.2% vs. 6.9%, P=0.028), less frequent neuropathy (23.4% vs. 30.4%, P<0.001), and fewer inpatient admissions (14.6% vs. 17.2%, P=0.030). Major medical complications did not differ in occurrence between the groups.Conclusions: Perioperative GLP-1 RA therapy in diabetic patients undergoing CuTR correlated with fewer 90-day emergency visits and lower 2-year risks of revisional surgery and ICD-coded ulnar neuropathy (all-cause, non-adjudicated).. These findings support a potential protective role of GLP-1 RAs in this surgical population. Evidence: III. KCI Citation Count: 0 |
| Author | Azad Ali Roban Shabbir Paulo E. L. Parente Simran Shamith Luke Nicholson |
| Author_xml | – sequence: 1 fullname: Roban Shabbir organization: (Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA) – sequence: 2 fullname: Simran Shamith organization: (Drexel University College of Medicine, Philadelphia, PA, USA) – sequence: 3 fullname: Paulo E. L. Parente organization: (Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA) – sequence: 4 fullname: Luke Nicholson organization: (Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, CA, USA) – sequence: 5 fullname: Azad Ali organization: (Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, CA, USA) |
| BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003270029$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNotjU1LAzEYhIMoWGvPXnMWtuZNmmx6LMWPQkGQel7y8W4NXZNlk_Uf-L9dq6cZmJlnbshlTBEJuQO2lGJdP7iQcckZl0vGNIMLMuNc60rXHC4nL7SotBD1NVnkHCxbKcWVBj4j39sPMxhXcAi5BJepiZ6msbj0iZmmlrrRhmI6WsYYsaMep6QfcMKkSEOkPhiL05L2pgSMJdMBHYavEI_02I3OHFOsunBC2mNfgscKzo2-pIH-htNvviVXrekyLv51Tt6fHg_bl2r_-rzbbvaVA1BQ1a1ptUOvjVLSQmu9sNrK1qO2znPplULhoAWLKw1Yw5ox56Rkdo0AQoo5uf_jxqFtTi40yYSzHlNzGprN22HXAKs101yJH7yAbFA |
| ContentType | Journal Article |
| DBID | ACYCR |
| DOI | 10.5397/cise.2025.00801 |
| DatabaseName | Korean Citation Index |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2288-8721 |
| EndPage | 410 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10780826 |
| GroupedDBID | 5-W 8JR ACYCR ALMA_UNASSIGNED_HOLDINGS EF. GROUPED_DOAJ JDI KVFHK OK1 PGMZT RPM |
| ID | FETCH-LOGICAL-c1161-7faf8ced8a665b1fbd3b8b5fde8bcd25d66e3c1f1be481e71900cc550b9e11353 |
| ISSN | 2383-8337 |
| IngestDate | Tue Dec 02 03:11:00 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1161-7faf8ced8a665b1fbd3b8b5fde8bcd25d66e3c1f1be481e71900cc550b9e11353 |
| Notes | http://www.cisejournal.org/journal/view.php?doi=10.5397/cise.2025.00801 |
| OpenAccessLink | https://www.cisejournal.org/upload/pdf/cise-2025-00801.pdf |
| PageCount | 8 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10780826 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-12 |
| PublicationDateYYYYMMDD | 2025-12-01 |
| PublicationDate_xml | – month: 12 year: 2025 text: 2025-12 |
| PublicationDecade | 2020 |
| PublicationTitle | Clinics in shoulder and elbow |
| PublicationYear | 2025 |
| Publisher | 대한견주관절학회 |
| Publisher_xml | – name: 대한견주관절학회 |
| SSID | ssib046626812 ssj0001510726 ssib053376781 |
| Score | 2.310403 |
| SecondaryResourceType | online_first |
| Snippet | Background: Cubital tunnel release (CuTR) relieves ulnar nerve compression; however, about 35% of patients who undergo this procedure develop persistent... |
| SourceID | nrf |
| SourceType | Open Website |
| StartPage | 403 |
| SubjectTerms | 정형외과학 |
| Title | Characteristics and outcomes of cubital tunnel decompression in diabetic patients receiving glucagon-like peptide-1 receptor agonists |
| URI | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003270029 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 대한 견주관절 학회지, 2025, 28(4), , pp.403-410 |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Directory of Open Access Journals (DOAJ) customDbUrl: eissn: 2288-8721 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001510726 issn: 2383-8337 databaseCode: DOA dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nj9MwELX2gwMXBALEx4IsQU5VSpPYjnNsSxBIqxWCRdpbFTuTJWpJqjRd7R_Y_804TtK0Qmg5cIks13KczpMzM3l-Q8j7NMS35gQ4Bjkec1nChasS8Nws0FyrNBSK22IT4cWFvLqKvh4dn3ZnYW5WYVHI29to_V9NjX1obHN09h_M3U-KHdhGo-MVzY7Xexl-_gcJ5nJb462svqzeKlMoZFRvDcVllIJhlVs2bMN6tNnYXHeSq-a7goa8STwYgntyXRbuKl_CaG0YMSm4XjNiXRs-Jv6I990MfV4rPdrwbjc_TUVtsLxNWKmyz6B_w32lMPLRSuU9X_h7_quyvSb_s_vatV2Vo3g8Oh-jA2zUpXpwnhuuCYIbt_RNi7c2o-HzA3aIE88cOTdEj_ijE3Enmjvx1Jn5zhQbc2caODPbw5ox2DNxpOwGR01jijPsdlJ0SwJXBlZdZgy2z0fcyNAez253bzYJBo4As3zbw3cMDxrtYlPzZGxWbwRy29XvqXkfvGX39LyXOl9cl4tltcCo5csCQ3CJrpg4Jqd-yCM5yAzgtsgEBp0DVTV00EPRSTTZw_A4gW_LKLYPakWszFI_HCwUfaiiygY-1OVj8qgNfujUgvYJOYLiKbk7ACxFbNAOsLTMaAtYagFL9wBL84J2gKUdYGkPWLoHWNoDlnaApR1gn5Efn-LL-We3LQ7iag-jFDfMkkxqSGUiBFdeptJAScWzFKTSqc9TISDQXuYpYNKDEB3fidYYj6sIPFPs5Tk5KcoCXhBqaIOaMcmAC6Z9qZJIcGAZeClnkfBfknf4lzVG-4vxXt1r1GvycAf5M3JSV1t4Qx7omzrfVG8bu_8G4XKjEw |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characteristics+and+outcomes+of+cubital+tunnel+decompression+in+diabetic+patients+receiving+glucagon-like+peptide-1+receptor+agonists&rft.jtitle=Clinics+in+shoulder+and+elbow&rft.au=Roban+Shabbir&rft.au=Simran+Shamith&rft.au=Paulo+E.+L.+Parente&rft.au=Luke+Nicholson&rft.date=2025-12-01&rft.pub=%EB%8C%80%ED%95%9C%EA%B2%AC%EC%A3%BC%EA%B4%80%EC%A0%88%ED%95%99%ED%9A%8C&rft.issn=2383-8337&rft.eissn=2288-8721&rft.spage=403&rft.epage=410&rft_id=info:doi/10.5397%2Fcise.2025.00801&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_10780826 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2383-8337&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2383-8337&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2383-8337&client=summon |